Breaking News
Get 60% Off 0
🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…
CLAIM SALE
Close

Generali Investments Sicav - Sri European Equity Fund Ax (0P000018PI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
248.742 -1.310    -0.52%
26/11 - Closed. Currency in EUR
Type:  Fund
Market:  Luxembourg
ISIN:  LU0145455142 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 421.98M
Generali Investments SICAV SRI European Equity F 248.742 -1.310 -0.52%

0P000018PI Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Generali Investments SICAV SRI European Equity F (0P000018PI) fund. Our Generali Investments SICAV SRI European Equity F portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 6.570 7.480 0.910
Stocks 93.430 93.430 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 11.910 14.322
Price to Book 1.529 2.080
Price to Sales 1.163 1.430
Price to Cash Flow 7.589 9.454
Dividend Yield 4.026 3.365
5 Years Earnings Growth 13.484 10.007

Sector Allocation

Name  Net % Category Average
Healthcare 20.530 15.147
Industrials 18.200 16.545
Financial Services 13.640 17.986
Consumer Cyclical 12.290 9.878
Technology 8.440 9.266
Consumer Defensive 8.090 11.096
Basic Materials 6.280 6.590
Communication Services 5.460 5.200
Utilities 4.640 4.604
Real Estate 2.430 1.883

Region Allocation

  • Europe Developed
  • Developed Markets

Top Holdings

Number of long holdings: 50

Number of short holdings: 6

Name ISIN Weight % Last Change %
  ASML Holding NL0010273215 5.16 627.70 -1.92%
  ASSA ABLOY B SE0007100581 5.10 327.2 -0.15%
  Societe Generale FR0000130809 4.55 24.55 -3.50%
  Renault FR0000131906 4.48 39.25 -0.71%
  Novartis CH0012005267 4.11 92.75 +0.89%
  Novo Nordisk B DK0062498333 4.05 743.4 -2.03%
  Unilever GB00B10RZP78 3.22 56.74 +1.00%
  Prysmian IT0004176001 2.91 62.1600 +0.58%
  AstraZeneca GB0009895292 2.81 10,532.0 +0.38%
  Santander ES0113900J37 2.58 4.3755 -0.46%

Top Equity Funds by Generali Investments Luxembourg SA

  Name Rating Total Assets YTD% 3Y% 10Y%
  Generali Komfort Dynamik Europa 1.34B 8.29 1.94 5.21
  LU0145456207 421.48M 9.48 3.27 5.80
  LU0169244745 421.48M 8.84 2.54 5.09
  Generali invs SICAV SRI Euro EqAY 421.48M 10.53 4.45 7.03
  LU0145455811 421.48M 9.98 3.83 6.40
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P000018PI Comments

Write your thoughts about Generali Investments Sicav - Sri European Equity Fund Ax
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email